CareDx, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $379.8M | $333.8M | $280.3M | $321.8M | $296.4M |
| Operating income | -$30.8M | $40.8M | -$203.4M | -$77.2M | -$29.7M |
| Operating expenses | $410.6M | $293.0M | $483.7M | $399.0M | $326.1M |
| Cash from operations | $42.0M | $38.0M | -$18.4M | -$25.2M | -$19.3M |
| Capital expenditure | $3.2M | $633,000 | $647,000 | $1.4M | $4.0M |
| Free cash flow | $38.8M | $37.4M | -$19.0M | -$26.7M | -$23.2M |
| Share repurchases | $87.8M | $522,000 | $27.5M | $642,000 | $0 |
| Impairments | $2.3M | $0 | $0 | $840,000 | $2.4M |
| Total assets | $413.2M | $491.1M | $466.8M | $543.0M | $566.6M |
| Total liabilities | $110.1M | $112.6M | $205.5M | $112.1M | $100.7M |
Shares outstanding 51.7M · Free float 85.4%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.